ESSA Pharma Inc (EPIX)
6.81
-0.17
(-2.44%)
USD |
NASDAQ |
May 07, 16:00
6.81
0.00 (0.00%)
After-Hours: 20:00
ESSA Pharma 1 Year Total Returns (Daily): 135.0% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 135.0% |
| May 03, 2024 | 141.4% |
| May 02, 2024 | 167.3% |
| May 01, 2024 | 145.2% |
| April 30, 2024 | 133.8% |
| April 29, 2024 | 123.3% |
| April 26, 2024 | 126.0% |
| April 25, 2024 | 128.4% |
| April 24, 2024 | 130.6% |
| April 23, 2024 | 130.2% |
| April 22, 2024 | 130.2% |
| April 19, 2024 | 122.5% |
| April 18, 2024 | 136.6% |
| April 17, 2024 | 150.7% |
| April 16, 2024 | 168.2% |
| April 15, 2024 | 163.5% |
| April 12, 2024 | 182.2% |
| April 11, 2024 | 182.5% |
| April 10, 2024 | 166.7% |
| April 09, 2024 | 154.3% |
| April 08, 2024 | 174.0% |
| April 05, 2024 | 188.0% |
| April 04, 2024 | 191.4% |
| April 03, 2024 | 170.3% |
| April 02, 2024 | 176.1% |
| Date | Value |
|---|---|
| April 01, 2024 | 183.5% |
| March 28, 2024 | 184.9% |
| March 27, 2024 | 179.7% |
| March 26, 2024 | 205.2% |
| March 25, 2024 | 211.7% |
| March 22, 2024 | 204.0% |
| March 21, 2024 | 201.3% |
| March 20, 2024 | 206.7% |
| March 19, 2024 | 213.1% |
| March 18, 2024 | 206.4% |
| March 15, 2024 | 212.5% |
| March 14, 2024 | 212.3% |
| March 13, 2024 | 226.4% |
| March 12, 2024 | 224.7% |
| March 11, 2024 | 227.6% |
| March 08, 2024 | 222.6% |
| March 07, 2024 | 200.7% |
| March 06, 2024 | 194.6% |
| March 05, 2024 | 192.3% |
| March 04, 2024 | 193.3% |
| March 01, 2024 | 187.0% |
| February 29, 2024 | 182.3% |
| February 28, 2024 | 161.5% |
| February 27, 2024 | 164.7% |
| February 26, 2024 | 152.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.56%
Minimum
Jul 12 2022
846.1%
Maximum
Mar 18 2021
73.24%
Average
29.93%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 9.80% |
| Aurinia Pharmaceuticals Inc | -55.36% |
| Edesa Biotech Inc | -38.27% |
| Lexaria Bioscience Corp | 158.8% |
| Xenon Pharmaceuticals Inc | 1.84% |